62 related articles for article (PubMed ID: 10482047)
1. Anti-neutrophil cell antibodies in newly diagnosed patients with type-1-diabetes.
Parlapiano C; Marangi M; Campana E; Giovanniello T; Pantone P; Suraci C; Sanguigni S
Exp Clin Endocrinol Diabetes; 1999; 107(5):328-9. PubMed ID: 10482047
[TBL] [Abstract][Full Text] [Related]
2. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
3. Anti platelet property of anti-single-stranded DNA antibodies in type 1 (insulin-dependent) diabetes mellitus.
Triolo G; Palumbo AA; Giardina E; Davi G; Triolo G
Diabetes Res; 1994; 26(2):79-87. PubMed ID: 7554728
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic control and antibody status among patients with newly diagnosed Type 1 diabetes.
Hickey D; Joshy G; Dunn P; Simmons D; Lawrenson R
N Z Med J; 2007 Sep; 120(1262):U2732. PubMed ID: 17891220
[TBL] [Abstract][Full Text] [Related]
5. Anti-ganglioside autoantibodies in type 1 diabetes.
Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
[TBL] [Abstract][Full Text] [Related]
6. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients.
Shervani NJ; Takasawa S; Uchigata Y; Akiyama T; Nakagawa K; Noguchi N; Takada H; Takahashi I; Yamauchi A; Ikeda T; Iwamoto Y; Nata K; Okamoto H
Eur J Clin Invest; 2004 Nov; 34(11):752-8. PubMed ID: 15530148
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in diabetes mellitus: current utility and perspectives.
Isermann B; Ritzel R; Zorn M; Schilling T; Nawroth PP
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):483-90. PubMed ID: 17853330
[TBL] [Abstract][Full Text] [Related]
9. Serum reactivity against RINm5F purified membrane antigens (ICMA) in newly diagnosed diabetic subjects.
Giordano C; Sapienza N; Mattina A; Pugliese A; Galluzzo A
Diabetes Res; 1990 Nov; 15(3):113-6. PubMed ID: 2132203
[TBL] [Abstract][Full Text] [Related]
10. A new ELISA assay for islet cell surface antibodies determination in type 1 diabetes mellitus of recent onset.
Bizzarro A; De Bellis A; Florio A; Gentile S; Amoresano Paglionico V; Cacciatore F; Iacono G
Horm Metab Res Suppl; 1992; 26():119-20. PubMed ID: 1490676
[TBL] [Abstract][Full Text] [Related]
11. Insulin autoantibodies: evidence of autoimmune disease among a group of Puerto Rican children with newly diagnosed type 1 diabetes mellitus.
González de Pijem L; Nieves-Rivera F
P R Health Sci J; 2001 Jun; 20(2):161-4. PubMed ID: 11561476
[TBL] [Abstract][Full Text] [Related]
12. [Insulin autoantibodies and insulin-induced antibodies in children with insulin-dependent diabetes].
Bridel MP; Tubiana-Rufi N; Levy-Marchal C
Diabete Metab; 1992; 18(6):459-62. PubMed ID: 1297603
[TBL] [Abstract][Full Text] [Related]
13. IgG auto-anti-idiotype antibodies against antibody to insulin in insulin-dependent (type 1) diabetes mellitus. Detection by capture enzyme linked immunosorbent assay (ELISA) and relationship with anti-insulin antibody levels.
Casiglia D; Giardina E; Triolo G
Diabetes Res; 1991 Apr; 16(4):181-4. PubMed ID: 1802485
[TBL] [Abstract][Full Text] [Related]
14. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
15. Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes.
Bilgic S; Aktas E; Salman F; Ersahin G; Erten G; Yilmaz MT; Deniz G
Diabetes Res Clin Pract; 2008 Jan; 79(1):31-6. PubMed ID: 17707941
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
17. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.
Lampasona V; Ferrari M; Bosi E; Pastore MR; Bingley PJ; Bonifacio E
J Autoimmun; 1994 Oct; 7(5):665-74. PubMed ID: 7840858
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling.
Dekki N; Nilsson R; Norgren S; Rössner SM; Appelskog I; Marcus C; Simell O; Pugliese A; Alejandro R; Ricordi C; Berggren PO; Juntti-Berggren L
Biosci Rep; 2007 Dec; 27(6):321-6. PubMed ID: 17597394
[TBL] [Abstract][Full Text] [Related]
19. Islet cell surface antibodies in diabetic children determined with 125I-labelled anti-IgG as tracer.
Hellström S; Ludvigsson J
Diabetes Res; 1992; 20(1):1-12. PubMed ID: 1344997
[TBL] [Abstract][Full Text] [Related]
20. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
